Cure Leukaemia works with the sole aim of eradicating blood cancer within a generation.

Founded in 2003, Cure Leukaemia works with the sole aim of eradicating blood cancer within a generation by funding the Trials Acceleration Programme (TAP) across 15 specialist centres across the UK. This integrated and collaborative network consists of 15 specialist research nurses in 15 of the UK's biggest cities. This network enables the accelerated setup, recruitment to and delivery of pioneering blood cancer clinical trials connecting patients from a catchment area of over 30 million people with potentially life-saving treatments not currently available through standard care.